{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/642e2a29c6ef3c0011602a23?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, April 6, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/show-cover.png?height=200","description":"<p>The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}